Fesoterodin Zentiva 4 mg, Retardtabletten - 84 Swissmedic Key 68694002 Registration Holder Helvepharm AG Name Fesoterodin Zentiva 4 mg, Retardtabletten Date of registration 31.03.2022 Original/Generic Generic Introduction of Sequence 31.03.2022 ATC-Classification Fesoterodine (G04BD11) Revision date WHO WHO-DDD Valid until 30.03.2027 Index Therapeuticus (BSV) 05.02. Show package size 84 Index Therapeuticus (Swissmedic) 05.02. Description Swissmedic categorie. B SL Eintrag Yes Indication Information for professionals IP Consumer information CI Ex-factory-Price 52.66 Limitation No Deductible 10 % Consumer price 73.70 Feedback FB Daily cost GTIN 7680686940024 Medication Code Synthetika Pharmacode Disponibility
Composition fesoterodini fumaras 4 mg corresp. fesoterodinum 3.1 mg, glyceroli dibehenas, hypromellosum, talcum, lactosum monohydricum 127.125 mg, cellulosum microcristallinum, Überzug: poly(alcohol vinylicus), talcum, E 171, glyceroli monocaprylocapras, natrii laurilsulfas, E 132, pro compresso obducto corresp. natrium 0.046 mg. Packungsbestandteile Galenic Form Delayed release tablets Active Agent Dose Fesoterodini Fumaras 4 mg correspond Fesoterodinum 3.1 mg
BAG: Active Agent Dose Fesoterodini Fumaras 4 mg
Inactive agents Dose additional_information Cellulosum Microcristallinum E 132 color. E 171 color. Glyceroli Dibehenas Glyceroli Monocaprylocapras Hypromellosum Lactose Monohydrate 127.125 mg Natrii Laurilsulfas Poly(Alcohol Vinylicus) Überzug Pro Compresso Obducto Talcum
Source Data was imported : 06.04.2022
Swissmedic Registration :
Sequence :
Product name :
Registration owner: :
Product group :
Index Therapeuticus (BSV) :
Medication Code :
Date of registration :
Valid until :
Package number :
Show package size :
Commercial Form/Unit :
Swissmedic categorie. :
Active Agents :
Composition :
